Pharmaceutical Packaging Industry Overview

The global pharmaceutical packaging market size is expected to reach USD 265.70 billion by 2030, registering a CAGR of 9.7% from 2024 to 2030, according to a new report by Grand View Research, Inc., The increasing prevalence of chronic diseases coupled with the growth of the pharmaceutical industry is anticipated to augment the consumption of pharmaceutical packaging products.

Ban on counterfeit products in North America and Europe is expected to be a major driver for the market as major companies are likely to invest heavily in anti-counterfeit packaging products. Blow-Fill-Seal (BFS) technology allows customized design for high-quality containers with tamper-evident closures in multiple shapes and sizes. Therefore, the growing demand for anti-counterfeiting packaging along with the advent of technology is likely to support the growth of tamper-evident pharmaceutical packaging.

Companies are focusing on using sustainable materials for packaging owing to the rising concerns about the generation of packaging waste that is difficult to degrade. Bioplastic is likely to gain traction in the market as it is derived from renewable plant-based sources and is biodegradable unlike plastics and polymers derived from fossil fuels. In May 2022, SGD Pharma has launched the industry’s first Ready-to-Use sterile 100 ml molded glass vials. It is manufactured with SG EZ-fill packaging technology. Such novel sustainable packaging solutions are expected to boost the growth of the market.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Packaging Market

Pharmaceutical manufacturers are likely to prefer blister packaging for tablets and capsules as these are more sustainable with minimal usage of packaging material as compared to rigid bottles. In addition, the transparency of blister packs provides a clear product display and provides tamper-resistant features. The outbreak of COVID-19 has significantly increased the demand for various pharmaceutical drugs across the world, thereby propelling the demand for pharmaceutical manufacturing and packaging. Rapid development and production of the vaccine in the year 2020 are anticipated to increase pharmaceutical manufacturing considerably, primarily benefitting the manufacturers of packaging vials in the near future.

Market players have been trying to increase their production capabilities as well as expand their geographic reach. In addition, companies are introducing and investing in high-tech packaging solutions in the changing environment. For instance, In April 2021, Amcor plc announced the development of recyclable Polyethylene-based thermoform blister packaging under the brand name AmSky. The development is aimed at sustainable packaging that can reduce carbon footprint. The product is expected to reduce carbon footprint up to 70%. Companies are expected to invest significantly in such developments in the coming years to strengthen their market position.

Browse through Grand View Research's Plastics, Polymers & Resins Industry Research Reports.

• The global polytetrafluoroethylene market size was valued at USD 3.63 billion in 2023 and is projected to grow at a CAGR of 5.5% from 2024 to 2030.
•  
• The global medical grade silicone market size was valued at USD 601.7 million in 2024 and is expected to register a CAGR of 7.4% from 2025 to 2030.

Pharmaceutical Packaging Market Segmentation

Grand View Research has segmented the pharmaceutical packaging market on the basis of on material, product, drug delivery mode, end-use, and region:

Pharmaceutical Packaging Material Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Plastics & Polymers
  • Polyvinyl Chloride (PVC)
  • Polypropylene (PP)
    • Homo
    • Random
  • Polyethylene Terephthalate (PET)
  • Polyethylene (PE)
    • HDPE
    • LDPE
    • LLDPE
  • Polystyrene (PS)
  • Others
• Paper & Paperboard
• Glass
• Aluminium Foil
• Others

Pharmaceutical Packaging Product Outlook (Revenue, USD Million, 2018 - 2030)

• Primary
  • Plastic Bottles
  • Caps & Closures
  • Parenteral Containers
    • Syringes
    • Vials & Ampoules
    • Others
  • Blister Packs
  • Prefillable Inhalers
  • Pouches
  • Medication Tubes
  • Others
• Secondary
  • Prescription Containers
  • Pharmaceutical Packaging Accessories
• Tertiary

Pharmaceutical Packaging Drug Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)

• Oral Drugs
• Injectables
• Topical
• Ocular/ Ophthalmic
• Nasal
• Pulmonary
• Transdermal
• IV Drugs
• Others

Pharmaceutical Packaging End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharma Manufacturing
• Contract Packaging
• Retail Pharmacy
• Institutional Pharmacy

Pharmaceutical Packaging Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Turkey
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Southeast Asia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Egypt

Key Companies profiled:

• Amcor plc
• Becton, Dickinson, and Company
• AptarGroup, Inc.
• Drug Plastics Group
• Gerresheimer AG
• Schott AG
• Owens Illinois, Inc.
• West Pharmaceutical Services, Inc.
• Berry Global, Inc.
• WestRock Company
• SGD Pharma
• International Paper
• Comar, LLC

Key Pharmaceutical Packaging Company Insights

The global market is highly competitive owing to the presence of numerous players across the globe. Moreover, key players are consolidating their market positions mainly by acquisitions, which is further intensifying the competition.

• In November 2023, Amcor Plc, a renowned global company known for its development and production of environmentally conscious packaging solutions, revealed a Memorandum of Understanding (MOU) with NOVA Chemicals Corporate, a leading producer of sustainable polyethylene. The agreement includes the procurement of mechanically recycled polyethylene resin (rPE) from NOVA Chemicals Corporate, which will be utilized in the production of flexible packaging films. This initiative aligns with Amcor's dedication to promoting packaging circularity by increasing the utilization of rPE in flexible packaging applications.
• In July 2023, Constantia Flexibles introduced a new pharmaceutical packaging solution called REGULA CIRC, which utilizes coldform foil. The packaging replaces conventional PVC with a PE sealing layer, resulting in a reduction in plastic content while increasing the proportion of aluminum. This optimization not only enhances the sustainability of the packaging but also improves material recovery during recycling processes.
• In April 2023, Südpack introduced its PharmaGuard blister, a polypropylene-based blister packaging. This new product offers an outstanding water vapor barrier along with effective barrier resistance against UV and oxygen.

Order a free sample PDF of the Pharmaceutical Packaging Market Intelligence Study, published by Grand View Research.